GB201908171D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB201908171D0
GB201908171D0 GBGB1908171.0A GB201908171A GB201908171D0 GB 201908171 D0 GB201908171 D0 GB 201908171D0 GB 201908171 A GB201908171 A GB 201908171A GB 201908171 D0 GB201908171 D0 GB 201908171D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1908171.0A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Instituto De Medicina Molecular Faculdade De Medicina Univ De Lisboa
Original Assignee
Instituto De Medicina Molecular Faculdade De Medicina Univ De Lisboa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instituto De Medicina Molecular Faculdade De Medicina Univ De Lisboa filed Critical Instituto De Medicina Molecular Faculdade De Medicina Univ De Lisboa
Priority to GBGB1908171.0A priority Critical patent/GB201908171D0/en
Publication of GB201908171D0 publication Critical patent/GB201908171D0/en
Priority to AU2020288706A priority patent/AU2020288706A1/en
Priority to PCT/EP2020/065730 priority patent/WO2020245430A1/fr
Priority to EP20732523.4A priority patent/EP3980126A1/fr
Priority to CA3140767A priority patent/CA3140767A1/fr
Priority to CN202080054085.5A priority patent/CN114206867A/zh
Ceased legal-status Critical Current

Links

GBGB1908171.0A 2019-06-07 2019-06-07 Compounds Ceased GB201908171D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB1908171.0A GB201908171D0 (en) 2019-06-07 2019-06-07 Compounds
AU2020288706A AU2020288706A1 (en) 2019-06-07 2020-06-05 Benzo[h][1,6] naphthyridin-2(1H)-ones as BMX inhibitors, for use against cancer
PCT/EP2020/065730 WO2020245430A1 (fr) 2019-06-07 2020-06-05 Benzo[h][1,6] naphtyridin-2(1h)-ones utilisés en tant qu'inhibiteurs de bmx destinés à être utilisés contre le cancer
EP20732523.4A EP3980126A1 (fr) 2019-06-07 2020-06-05 Benzo[h][1,6] naphtyridin-2(1h)-ones utilisés en tant qu'inhibiteurs de bmx destinés à être utilisés contre le cancer
CA3140767A CA3140767A1 (fr) 2019-06-07 2020-06-05 Benzo[h][1,6] naphtyridin-2(1h)-ones utilises en tant qu'inhibiteurs de bmx destines a etre utilises contre le cancer
CN202080054085.5A CN114206867A (zh) 2019-06-07 2020-06-05 用于对抗癌症的作为bmx抑制剂的苯并[h][1,6]萘啶-2(1h)-酮

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1908171.0A GB201908171D0 (en) 2019-06-07 2019-06-07 Compounds

Publications (1)

Publication Number Publication Date
GB201908171D0 true GB201908171D0 (en) 2019-07-24

Family

ID=67386187

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1908171.0A Ceased GB201908171D0 (en) 2019-06-07 2019-06-07 Compounds

Country Status (6)

Country Link
EP (1) EP3980126A1 (fr)
CN (1) CN114206867A (fr)
AU (1) AU2020288706A1 (fr)
CA (1) CA3140767A1 (fr)
GB (1) GB201908171D0 (fr)
WO (1) WO2020245430A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115124524A (zh) * 2021-03-26 2022-09-30 浙江海正药业股份有限公司 三环类衍生物及其制备方法和用途
US12030883B2 (en) * 2021-09-21 2024-07-09 Incyte Corporation Hetero-tricyclic compounds as inhibitors of KRAS

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013154778A1 (fr) 2012-04-11 2013-10-17 Dana-Farber Cancer Institute, Inc. Inhibiteurs ciblant l'hôte du virus de la dengue et d'autres virus
US10000483B2 (en) * 2012-10-19 2018-06-19 Dana-Farber Cancer Institute, Inc. Bone marrow on X chromosome kinase (BMX) inhibitors and uses thereof
CN104829610B (zh) * 2014-06-20 2017-03-15 中国科学院合肥物质科学研究院 一种新型布鲁顿酪氨酸激酶抑制剂

Also Published As

Publication number Publication date
WO2020245430A1 (fr) 2020-12-10
CA3140767A1 (fr) 2020-12-10
AU2020288706A1 (en) 2022-01-06
CN114206867A (zh) 2022-03-18
EP3980126A1 (fr) 2022-04-13

Similar Documents

Publication Publication Date Title
IL292753A (en) compounds
IL289463A (en) Agonist-gipr compounds
GB201905721D0 (en) Compounds
GB201916915D0 (en) Compounds
GB201910305D0 (en) Compounds
GB201908536D0 (en) Compounds
GB201908171D0 (en) Compounds
GB201910304D0 (en) Compounds
GB201908095D0 (en) Carboxy-MIDA-boronate compounds
GB201919205D0 (en) Compounds
GB201918761D0 (en) Compounds
GB201918424D0 (en) Compounds
GB201917895D0 (en) Compounds
GB201917893D0 (en) Compounds
GB201917891D0 (en) Compounds
GB201916847D0 (en) Compounds
GB201916595D0 (en) Compounds
GB201916597D0 (en) Compounds
GB201916572D0 (en) Compounds
GB201916142D0 (en) Compounds
GB201914208D0 (en) Compounds
GB201913633D0 (en) Compounds
GB201913541D0 (en) Compounds
GB201912850D0 (en) Compounds
GB201911848D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)